发明名称 HETEROCYCLIC COMPOUND
摘要 The problem of the present invention is to provide a compound having a PDE2A inhibitory action, and useful as a prophylactic or therapeutic drug for schizophrenia, Alzheimer's disease and the like. The present invention relates to a compound represented by the formula (I): wherein each symbol is as described in the DESCRIPTION, or a salt thereof.
申请公布号 EP3061754(A4) 申请公布日期 2017.03.22
申请号 EP20140856224 申请日期 2014.10.22
申请人 Takeda Pharmaceutical Company Limited 发明人 SETO, Masaki;BANNO, Yoshihiro;IMAEDA, Toshihiro;KAJITA, Yuichi;ASHIZAWA, Tomoko;KAWASAKI, Masanori;NAKAMURA, Shinji;MIKAMI, Satoshi;NOMURA, Izumi;TANIGUCHI, Takahiko;MARUI, Shogo
分类号 C07D239/28;A61K31/426;A61K31/4965;A61K31/497;A61K31/505;A61K31/506;A61K31/5377;A61K31/5386;A61K31/55;A61P25/18;A61P25/28;A61P43/00;C07D239/36;C07D239/42;C07D239/47;C07D239/48;C07D239/54;C07D239/56;C07D241/24;C07D241/26;C07D277/20 主分类号 C07D239/28
代理机构 代理人
主权项
地址